0.95 +0.07 (7.78%)
BCRX
Stock Details
Last Trade:0.95 Change:+0.07 (7.78%) Prev Close:0.88 Open: 0.90 Days Range:0.89 – 1.02 52 Week Range: 0.85 - 6.85 Volume:96373 P/E: N/AEPS:-0.94
View AllRecent Alerts 11/21/08
Recent Alert on 10/31/08 at 8:16am
BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss of $0.24, Beats by a Penny
BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss of $0.24, Beats by a Penny
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) reports Q3 loss of $0.24, 1 cent better than the analyst estimate of ($0.25). Revenue for the quarter was $8.9 million, versus the consensus of $6.35 million.
Recent Alert on 10/27/08 at 9:56am
BioCryst Pharmaceuticals (BCRX) Reports Results of Phase 2 Trial on Peramivir
BioCryst Pharmaceuticals (BCRX) Reports Results of Phase 2 Trial on Peramivir
Recent Alert on 09/04/08 at 9:03am
BioCryst Pharma (BCRX) Reports Results From BCX-4208 Phase IIa Trial in Subjects With Psoriasis
BioCryst Pharma (BCRX) Reports Results From BCX-4208 Phase IIa Trial in Subjects With Psoriasis
Recent Alert on 09/04/08 at 9:03am
BioCryst Pharma (BCRX) Reports Results From BCX-4208 Phase IIa Trial in Subjects With Psoriasis
BioCryst Pharma (BCRX) Reports Results From BCX-4208 Phase IIa Trial in Subjects With Psoriasis
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available